Adrian Quartel

Adrian Quartel has extensive work experience in the medical field. Adrian is currently serving as the Chief Medical Officer at Zevra Therapeutics since 2024. Prior to this role, they held the same position at Acer Therapeutics Inc. from 2022 to 2024, and at Adamas Pharmaceuticals, Inc. from 2020 to 2022. Adrian also has experience working at BioMarin Pharmaceutical Inc., where they held various leadership roles in medical affairs from 2007 to 2020. Before that, they worked at Chiltern int as the Medical Director UK, Astellas Pharma as the European Medical Affairs Manager, ICON Clinical Research as a Senior Clinical Research Physician, and California Clinical Trials as a Clinical Research Coordinator. Adrian began their career as a SHO Thoracic Surgery at Erasmus MC and later worked as a Research Fellow at Cedars-Sinai Medical Center.

Adrian Quartel completed their Doctor of Medicine (M.D.) degree in medicine from Erasmus University Rotterdam between 1988 and 1996. Adrian then pursued further education at Cardiff University / Prifysgol Caerdydd from 2004 to 2006. Adrian then attended the Royal College of Physicians from 2006 to 2012, studying Pharmaceutical Medicine. Finally, they became a Fellow of the Faculty of Pharmaceutical Medicine in 2017.